Found 36 matching trials
Lumateperone in the Treatment of Stuttering, Childhood Onset Fluency Disorder PHASE2 The primary objective of this study is to evaluate the efficacy and tolerab...
Show More Learn More & Join Trial
Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia PHASE1 This is an open-label study to determine the pharmacokinetics, safety and t...
Show More Learn More & Join Trial
The Effects of Lumateperone on Obesity and Physiologic Aging and Their Association With Antidepressant Response in Bipolar Depression PHASE4 This research study examines how a medication called lumateperone may affec...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder PHASE1 Study ITI-007-020 is a Phase 1b, multicenter, open-label study to evaluate ...
Show More Learn More & Join Trial
A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment PHASE3 The study will evaluate the antipsychotic efficacy of ITI-007 in a randomiz...
Show More Learn More & Join Trial
Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression PHASE3 The study will evaluate the efficacy and safety of ITI-007 (Lumateperone) i...
Show More Learn More & Join Trial
Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia PHASE4 The main question this study is trying to answer is whether lumateperone, a...
Show More Location
UMass Chan Medical School
Learn More & Join Trial
Neurocircuitry Mechanisms and Efficacy of Lumateperone as Adjunctive Therapy for Major Depressive Disorder and History of Early Life Abuse PHASE4 The purpose of this clinical research study is to understand how effective ...
Show More Location
Health Discovery Building
Learn More & Join Trial
ITI-007 (Lumateperone Tosylate) for Schizophrenia PHASE2 The purpose of this study is to offer open label ITI-007 treatment to patie...
Show More Location
New York State Psychiatric Institute
Learn More & Join Trial
This Study Aims to Compare the Efficacy and Safety of Lumateperone and Cariprazine in Patients With Bipolar I Depression Using Montgomery-Åsberg Depression Rating Scale (MADRS) and Clinical Global Impression Bipolar Severity Scale (CGI-BP-S) and Recording Treatment Emergent Adverse Effects. PHASE4 This study aims to compare the efficacy and safety of lumateperone and cari...
Show More Location
Multiple Locations
Learn More & Join Trial